Elevance Health (ELV) Net Cash Flow (2010 - 2026)

Elevance Health (ELV) has 17 years of Net Cash Flow data on file, last reported at $175.0 million in Q1 2026.

• Net Cash Flow for Q1 2026 came in at $175.0 million, up 122.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 61.49% YoY), and the FY2025 annual result was $1.2 billion, down 34.13% from the prior year.
• Net Cash Flow retreated to $175.0 million in Q1 2026 per ELV's latest filing, from $784.0 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $2.8 billion in Q1 2023 and troughed at -$4.4 billion in Q4 2023.
• A 5-year average of $286.9 million and a median of $301.0 million in 2022 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2022 and 2023: Net Cash Flow jumped 935.04% in 2022, then slumped 195.49% in 2023.
• A 5-year view of Net Cash Flow shows it stood at -$1.5 billion in 2022, then tumbled by 195.49% to -$4.4 billion in 2023, then jumped by 110.83% to $476.0 million in 2024, then jumped by 64.71% to $784.0 million in 2025, then slumped by 77.68% to $175.0 million in 2026.
• Business Quant data shows ELV's Net Cash Flow at $175.0 million in Q1 2026, $784.0 million in Q4 2025, and $154.0 million in Q3 2025.